Is Cannabidiol (CBD) safe in cosmetics?
Cannabidiol (CBD) has a safety rating of "GOOD" in our database. EU status: permitted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Also known as: 1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, 1,3-Benzenediol, 2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, (1R-trans)-, 2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3- benzenediol, (-)-Cannabidiol, Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, trans-(-)- (+7 more)
INCI: CANNABIDIOL
Cannabidiol (CBD) (CAS 13956-29-1) is a cosmetic cosmetic ingredient functioning as Insufficient data available. Reported NOAEL =80 mg/kg bw/day in rabbit (New Zealand White; male/female) (FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z); EU Regulation 1223/2009 status: permitted, max 0.19%. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in pharmaceutical data.
View industrial chemical safety profile for CAS 13956-29-1 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Cannabidiol (CBD).
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Cannabidiol (CBD). NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =80 mg/kg bw/day | oral: gavage | rabbit (New Zealand White; male/female) | developmental toxicity teratogenicity | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =80 mg/kg bw/day | oral: gavage | rabbit (New Zealand White; male/female) | developmental toxicity teratogenicity | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =80 mg/kg bw/day | oral: gavage | rabbit (New Zealand White; male/female) | developmental toxicity teratogenicity | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =80 mg/kg bw/day | oral: gavage | rabbit (New Zealand White; male/female) | developmental toxicity teratogenicity | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =400 mg/kg bw/day | oral: gavage | mouse (CD-1; male) | repeated dose toxicity oral | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =400 mg/kg bw/day | oral: gavage | mouse (CD-1; male) | repeated dose toxicity oral | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =400 mg/kg bw/day | oral: gavage | mouse (CD-1; male) | repeated dose toxicity oral | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =400 mg/kg bw/day | oral: gavage | mouse (CD-1; male) | repeated dose toxicity oral | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =550 mg/kg bw/day | oral: gavage | mouse (CD-1; female) | repeated dose toxicity oral | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
| NOAEL | =550 mg/kg bw/day | oral: gavage | mouse (CD-1; female) | repeated dose toxicity oral | FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z |
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| CN | banned | - | - |
Expert safety assessment and concern-level summary for Cannabidiol (CBD).
Public NOAEL study rows linked to Cannabidiol (CBD) by CAS number or substance name.
Units vary across source rows: mg/kg bw/day, mg/kg/day, mg/kg
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Cannabidiol (CBD) has a safety rating of "GOOD" in our database. EU status: permitted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Cannabidiol (CBD) EU regulatory status: permitted. Maximum allowed concentration: 0.19%. This is based on EU Regulation 1223/2009 and its amendments.
Cannabidiol (CBD) functions as: Insufficient data available. It is classified as a cosmetic ingredient in our database. CAS number: 13956-29-1.
The NOAEL (No Observed Adverse Effect Level) for Cannabidiol (CBD) is =80 mg/kg bw/day based on a developmental toxicity teratogenicity study via oral: gavage route in rabbit (New Zealand White; male/female). A total of 10 study endpoints are available. Source: FDA_Toxicity_33a0e61f-e087-4928-acb3-56a237369802_dossier.i6z.
Cannabidiol (CBD) also appears in pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Cannabidiol (CBD) compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Cannabidiol (CBD) in your formulation.